Product category:
Chemical Process Industry News
News Release from: Frost and Sullivan
Edited by the Processingtalk Editorial
Team on 18 December 2003
Award for chemical technology start-up
company
Netherlands-based technology start-up SupraPolix BV has been honoured with the 2003 Frost and Sullivan Entrepreneurial Company of the Year award for the specialty chemicals industry
Netherlands-based technology start-up SupraPolix BV has been honoured with the 2003 Frost and Sullivan Entrepreneurial Company of the Year award for the specialty chemicals industry The award recognises the SupraPolix BV superior entrepreneurial ability in commercialising its proprietary supramolecular technology platform
This article was originally published on Processingtalk on 7 Feb 2003 at 8.00am (UK)
Related stories
The HIV/AIDS Therapies Market
While antiretroviral drugs in existing categories continue to be the mainstay of the HIV/AIDS therapies market in the United States, the development of new drugs offers exciting growth prospects
The European breast cancer pharmaceuticals market
The quest for a breast cancer wonder drug, and improved survival rates, continue to pump up business in the breast cancer pharmaceutical industry
Powered by the concept of supramolecular interactions, their technology platform alters the properties of polymeric materials, facilitating improved processability.
The inclusion of a small quantity of their product SupraB (based on the multiple hydrogen bonding approach) in existing plastics introduces reversible cross-links.
It thereby simplifies their processing and significantly enlarges the scope of applications of existing plastics.
Further reading
Proteomics sample preparations markets
Integrated, customised, and validated research solutions for proteomics analyses and drug discoveries will fuel growth in the sample preparations market, according to the latest market resaerch report
Portfolio management in pharmaceutical market
Portfolio management carves a niche for itself in the resource-constrained pharmaceutical market, based on the need to identify and prioritise the most profitable projects in the R and D pipeline
Pharma rethinks traditional product marketing
A resurgent disease management sector will compel pharmaceutical companies to market products as constituents of packages of care, re-directing their sales efforts towards planners rather than doctors
"The large variety of possible applications of SupraB in most of the well known "traditional" polymers makes it a very attractive technology platform," notes Frost and Sullivan Industry Analyst Evelyne Turmes.
"Potential applications include, amongst others, novel thermoplastic elastomers, superglues, hotmelts and plastic electronics".
Other discernible advantages of using this technology include shorter processing times resulting in rapid and economical production as well as reduced energy consumption.
Reversible property changes allow for materials that can self-heal and be recycled.
Clearly, these advantages converge in more environmentally benign systems.
By supporting modifications to material properties, SupraB also promotes the creation of customised polymers.
Using SupraB, SupraPolix has developed a portfolio of materials containing reversible supramolecular polymers.
In addition, it has forged strategic partnerships with industry participants to apply the technology to their materials as well.
"By supplying its customers with specific licence agreements for the application of SupraB in one specific commercial application at a time, and by close cooperation with its customers on R and D, SupraPolix is in an excellent position to maximise its growth potential," says Frost and Sullivan Industry Analyst Evelyne Turmes.
As one of the first to subscribe to the SupraPolix innovative technology, DSM has continued to invest heavily in the company.
The alliance with DSM has boosted SupraPolix profile among prospective international clients.
Successful first round financing has been realised from DSM Venturing, TU/e Holding and other private investors.
In presenting SupraPolix with the 2003 Entrepreneurial Company of the Year award, Frost and Sullivan recognises it as "the small company that has identified a unique and bold product solution with significant market potential and has designed a sound market strategy that appears poised for success".
About SupraPolix.
SupraPolix BV, originating from the Eindhoven University of Technology in the Netherlands, was founded in 2002.
SupraPolix offers a new concept in the world of plastics by separating the processability demands from the material demands: incorporation of already a small amount of its product SupraB in existing plastics dramatically simplifies their processing.
As a consequence, production can be cheaper and faster, whereas the consumer will benefit from innovated products that are easier to use.
The reduced energy consumption during processing and the improved recycling of the materials makes the technology environmentally benign.
Implementation of the technology allows producers to comply with the environmental constraints of the near future without any concession to the quality of the materials.
• Frost and Sullivan: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
Search the Pro-Talk network of sites
